
OC2011_Treatment of Acute Lymphoblastic Leukemia (ALL) in Adults
Partow Kebriaei MD M.D. Anderson Cancer Center
28mins
19 Dec 2011
Rank #1

New Treatment Options for Prostate Cancer: Immunotherapy, Chemotherapy, Angiogenesis
SANDY SRINIVAS, M.D.Associate Prof Medicine Stanford University Stanford, CA
28mins
6 May 2011
Rank #2

OC2011_Management of Invasive Bladder Cancer
Randall E. Millikan, MD The University of Texas MD Anderson Cancer Center
42mins
19 Dec 2011
Rank #3

OC2011_Principles of HER2+ Breast Cancer Management
Debu Tripathy, MD USC/Norris Comprehensive Cancer
33mins
19 Dec 2011
Rank #4
Most Popular Podcasts

Appropriate Use of Aromatase Inhibitors for Breast Cancer in Postmenopausal Women
Presented by Dr. Beverly Moy, MD, MPH
28mins
25 Aug 2010
Rank #5

OC2011_Molecular Decision-Making and Chemotherapy in Early Stage Breast Cancer
Ruth M. O’Regan, MD Emory University School of Medicine
36mins
19 Dec 2011
Rank #6

The Evolving Molecular Pathology of Lung Cancer: The Modern Auerbach - OC 2010
William Dean Wallace David Geffen School of Medicine at the UCLA Medical Center Department of Pathology and Laboratory Medicine
28mins
26 Apr 2011
Rank #7

Clinical Applications of the New Staging System for Lung Cancer - OC 2010
Stephen G. Swisher, M.D., F.A.C.S. Department Chair, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX Professor, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX Robert F. Fly Professorship of Surgical Oncology, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX
24mins
26 Apr 2011
Rank #8

EGFR Mutation Testing and How it may influence Therapy in Patients with NSCLC
Presented by Dr. Corey Langer, MD
34mins
25 Aug 2010
Rank #9

Metastatic Breast Cancer: The Problem of Resistance
Ruth O'Regan, MD Associate Professor of Hematology and Oncology Director of Translational Breast Cancer Research Program Emory University
36mins
22 Oct 2010
Rank #10

Ideal Duration of Adjuvant Hormone Therapy in Breast Cancer
Presented by Dr. Beverly Moy, MD, MPH
19mins
25 Aug 2010
Rank #11

Options for Management of Bone Metastases of Prostate Cancer
A. Oliver Sartor, M.D Tulane University Hospital New Orleans, LA
28mins
6 May 2011
Rank #12

Metastatic Breast Cancer: The Problem of Resistance
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 14.0px Helvetica} span.s1 {letter-spacing: 0.0px} Ruth M. O’Regan, MD Associate Professor of Hematology and Oncology Director Translational Breast Cancer Research Program, Department of Hematology and Medical Oncology
38mins
22 Oct 2010
Rank #13

OC2011_Incidence of Adverse Oral Outcomes in Cancer Patients
Michael T. Brennan DDS, MHS Carolinas Medical Center
44mins
19 Dec 2011
Rank #14

OC2011_Kidney Cancer Update, Novel Targeted Therapies and Surgical Interventions
Lauren C. Harshman, MD Stanford School of Medicine
49mins
19 Dec 2011
Rank #15

OC2011_Management and Novel Targets of Hodgkin’s Lymphoma
Mary Jo Lechowicz, MD Winship Cancer Institute Emory University
24mins
19 Dec 2011
Rank #16

OC2011_Managing Complicated NSCLC Cases
Martin J. Edelman, MD University of Maryland Greenebaum Cancer Center
8mins
19 Dec 2011
Rank #17

OC2011_Systemic Therapy for Lung Cancer
Martin J. Edelman, MD University of Maryland School of Medicine
32mins
19 Dec 2011
Rank #18

OC2011_The Puzzel of Cancer Pain and Its Treatment
Tamara King, PhD University of Arizona Arizona Cancer Center
48mins
19 Dec 2011
Rank #19

OC2011_Update in Molecular Pathology of Lung Cancer
W. Dean Wallace, MD David Geffen School of Medicine at UCLA
50mins
19 Dec 2011
Rank #20